Estradiol hexahydrobenzoate
 | |
| Clinical data | |
|---|---|
| Trade names | Benzo-Ginoestril A.P., BenzoGynoestryl Retard, Ginestryl-15-Depot, Menodin, Tardoginestryl |
| Synonyms | 17β-Hexahydrobenzoylestradiol; Estradiol 17β-cyclohexanecarboxylate |
| Routes of administration | Intramuscular injection |
| Drug class | Estrogen; Estrogen ester |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| Chemical and physical data | |
| Formula | C25H34O3 |
| Molar mass | 382.54 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Estradiol hexahydrobenzoate (INN), sold under the brand names Benzo-Ginoestril A.P., BenzoGynoestryl Retard, Ginestryl-15-Depot, Menodin, and Tardoginestryl and also known as estradiol 17β-cyclohexanecarboxylate, is an estrogen and an estrogen ester which has been used in Europe.[1][2][3] It is an estrogen ester, specifically, an ester of estradiol.[1][2] It is or was marketed in France in a 5 mg/mL solution for intramuscular injection.[3]
See also
References
- 1 2 J. Elks (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 898. ISBN 978-1-4757-2085-3.
- 1 2 I.K. Morton; Judith M. Hall (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 114, 206. ISBN 978-94-011-4439-1.
- 1 2 Muller (19 June 1998). European Drug Index: European Drug Registrations, Fourth Edition. CRC Press. pp. 150–. ISBN 978-3-7692-2114-5.
This article is issued from
Wikipedia.
The text is licensed under Creative Commons - Attribution - Sharealike.
Additional terms may apply for the media files.